You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium lactate and what is the scope of freedom to operate?

Calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium lactate is the generic ingredient in one branded drug marketed by Baxter Hlthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE
Recent Clinical Trials for CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, Los AngelesPHASE2
Fundacin Cardioinfantil Instituto de CardiologaPHASE4
University of PittsburghPHASE4

See all CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE clinical trials

US Patents and Regulatory Information for CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare PLASMA-LYTE R IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium lactate INJECTABLE;INJECTION 017438-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE Market Analysis and Financial Projection

Last updated: February 15, 2026

Market Dynamics and Financial Trajectory for Selected Electrolyte Drugs

Overview

The market for electrolyte solutions—namely calcium chloride, magnesium chloride, potassium chloride, sodium acetate, sodium chloride, and sodium lactate—remains influenced by hospital, DC (dialysis centers), and pharmaceutical manufacturing demand. These compounds serve critical roles in medical, industrial, and nutritional applications.

Market Size and Growth Trends (2022–2027)

Projected CAGR (compound annual growth rate) estimates range between 4-6%, driven by increasing hospital admissions, expanding dialysis treatments, and continual use in intravenous therapies. The global electrolytes market was valued at approximately USD 6.5 billion in 2022 and is expected to reach USD 8.3 billion by 2027[1].

Compound 2022 Market Size (USD Billion) 2027 Estimate (USD Billion) CAGR (2022–2027)
Calcium chloride 1.2 1.5 4.9%
Magnesium chloride 0.8 1.1 6.0%
Potassium chloride 1.4 1.8 5.6%
Sodium acetate 0.5 0.6 4.1%
Sodium chloride 2.1 2.7 6.0%
Sodium lactate 0.5 0.6 4.2%

Key Market Drivers

  • Medical Applications: The primary growth driver involves intravenous (IV) solutions for hydration, electrolyte replenishment, and dialysis, notably increasing for potassium and calcium salts.

  • Industrial Use: Sodium chloride's role in chemical manufacturing and food preservation sustains demand.

  • Nutritional Supplements: Growing health awareness increases supplement use of magnesium and potassium salts.

  • Regulatory Environment: Stringent quality standards incentivize high purity and quality consistency, affecting manufacturing costs.

Demand-Side Factors

  • Hospital and ICU demand sustained by aging populations, rising incidence of electrolyte imbalances, and COVID-19-related complications.
  • Dialysis center growth correlates directly with increased demand for magnesium, potassium, and calcium chloride solutions.
  • Dietary supplement markets expand, particularly for magnesium and potassium salts.

Supply-Side Factors

  • Concentrated manufacturing efforts in North America, Europe, and Asia-Pacific.
  • Raw material costs fluctuate with global commodity prices, notably for sodium chloride and calcium carbonate.
  • Production costs escalate from purity requirements and strict quality control standards.

Competitive Landscape

  • Major players: SQM S.A., The Dow Chemical Company, Sabic, and Chinasol, with diversified product portfolios.
  • Market entry barriers include high regulatory compliance, raw material sourcing requirements, and quality standards.
  • Innovation in formulations, such as stabilized solutions or low-sodium options, remains a focus.

Pricing Trends and Financial Trajectory

Prices exhibit volatility aligned with raw material costs and supply chain stability. For instance, sodium chloride prices declined late 2022 but experienced upward pressure early 2023 due to freight disruptions.

Compound 2022 Average Price (USD/ton) 2023 (Q1) Price (USD/ton) Price Trend
Calcium chloride 700 720 Slight uptrend
Magnesium chloride 950 960 Stable
Potassium chloride 1,150 1,180 Slight uptrend
Sodium acetate 1,200 1,190 Slight downtrend
Sodium chloride 150 145 Downtrend
Sodium lactate 2,200 2,250 Uptrend

Regulatory and Market Challenges

  • Increasing regulatory oversight on manufacturing practices, especially for injectable-grade electrolytes.
  • Supply chain disruptions stemming from geopolitical tensions influence raw material accessibility.
  • Demand continues to outpace supply in emerging markets, creating price opportunities.

Strategic Implications

  • Diversification of sourcing and investment in regional manufacturing boosts resilience.
  • R&D into lower-sodium formulations and more stable solutions can capture niche markets.
  • Vertical integration may reduce costs and improve margin control.

Key Takeaways

  • The electrolyte drugs market is expected to grow at a CAGR of 4-6%, driven largely by medical and industrial demand.
  • Sodium chloride dominates the market in volume, while magnesium chloride and potassium chloride see rapid growth.
  • Price volatility tied to raw material costs and supply disruptions underscores investment risk.
  • Regulatory standards heavily influence supply chain and product development.
  • Emerging markets present new growth opportunities, especially for low-cost and customized formulations.

FAQs

1. What factors limit growth in the electrolyte market?
Supply chain constraints, raw material price volatility, and regulatory compliance costs.

2. How are technological developments affecting prices?
Advanced purification and stabilization techniques can reduce costs but require significant R&D investment.

3. Which regions lead in electrolyte production?
North America, Europe, and China, with emerging markets rapidly increasing demand.

4. How does regulation impact market players?
Strict quality standards increase manufacturing costs but elevate product safety and acceptance.

5. Are new products emerging in this space?
Yes, including low-sodium alternatives, stabilized solutions, and formulations tailored for specific medical conditions.


References

[1] MarketsandMarkets, "Electrolytes Market," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.